AI
TEVA icon

Atria Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Atria Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
39,602
+6,650
+20% +$221K 0.01% 961
2026
Q1 		$993K Buy
32,952
+13,932
+73% +$448K 0.01% 1057
2025
Q4 		$594K Buy
+19,020
New +$469K 0.01% 1334
2025
Q2 		– Sell
-21,055
Closed -$324K – 2075
2025
Q1 		$324K Sell
21,055
-2,898
-12% -$51.8K ﹤0.01% 1579
2024
Q4 		$528K Sell
23,953
-6,903
-22% -$126K 0.01% 1297
2024
Q3 		$556K Buy
30,856
+17,746
+135% +$311K 0.01% 1265
2024
Q2 		$213K Buy
+13,110
New +$202K ﹤0.01% 1788

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Atria Investments's TEVA Position: Q2 2026 in Review

Atria Investments increased its Teva Pharmaceuticals (TEVA) stake by 20% in Q2 2026, buying an estimated $221K and bringing the position to 39,602 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #961.

Atria Investments first reported a position in TEVA in Q2 2024 and has held it in 7 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Atria Investments held 39,602 shares of Teva Pharmaceuticals worth $1.34M as of Q2 2026.
  • Atria Investments bought 6,650 Teva Pharmaceuticals shares in Q2 2026, an estimated $221K.
  • Teva Pharmaceuticals made up 0.01% of Atria Investments's portfolio in Q2 2026, its #961 holding.
  • Atria Investments first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.